O(6)-Benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma

This study has been completed.

Study NCT00003613 Information provided by Case Comprehensive Cancer Center

First Received: November 1, 1999 Last Updated: June 10, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2007
Primary Completion Date:	May 2006 (Final data collection date for primary outcome measure)